Egetis Therapeutics AB (publ) (LON:0ABW)
4.985
-0.175 (-3.39%)
At close: Feb 11, 2026
-16.64% (1Y)
| Market Cap | 163.66M +2.1% |
| Revenue (ttm) | 4.37M -18.4% |
| Net Income | -26.31M |
| EPS | -0.07 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 11.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,782 |
| Average Volume | 21,791 |
| Open | 5.000 |
| Previous Close | 5.160 |
| Day's Range | 4.965 - 5.000 |
| 52-Week Range | 3.105 - 6.870 |
| Beta | 1.13 |
| RSI | 48.87 |
| Earnings Date | Feb 26, 2026 |